Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Elastic
ESTC
$7.39B
| $391K | ﹤0.01% |
2,682
-147,070
| -98% | -$18.4M |
|
3177
MannKind Corp
MNKD
$1.22B
| $390K | ﹤0.01% |
71,527
-143,794
| -67% | -$623K |
|
3178
Anika Therapeutics
ANIK
$262M
| $389K | ﹤0.01% |
8,986
-18,551
| -67% | -$790K |
|
3179
iShares MSCI India ETF
INDA
$6.65B
| $388K | ﹤0.01% |
8,780
-150,202
| -94% | -$6.44M |
|
|
ATSG
3180
DELISTED
Air Transport Services Group
ATSG
| $388K | ﹤0.01% |
16,654
-41,501
| -71% | -$1.07M |
|
|
RFP
3181
DELISTED
Resolute Forest Products Inc.
RFP
| $388K | ﹤0.01% |
31,804
+21,604
| +212% | +$303K |
|
|
GTT
3182
PUT
DELISTED
GTT Communications, Inc.
GTT
| $388K | ﹤0.01% |
+160,000
| New | +$311K |
|
3183
Kadant
KAI
$3.95B
| $387K | ﹤0.01% |
2,200
-8,165
| -79% | -$1.44M |
|
3184
Nature's Sunshine
NATR
$360M
| $386K | ﹤0.01% |
22,221
+14,810
| +200% | +$293K |
|
3185
Comtech Telecommunications
CMTL
$50.6M
| $385K | ﹤0.01% |
15,925
-18,976
| -54% | -$463K |
|
3186
PUT
Eaton
ETN
$173B
| $385K | ﹤0.01% |
2,600
| – | – |
|
3187
GrowGeneration
GRWG
$89.5M
| $385K | ﹤0.01% |
8,018
-27,523
| -77% | -$1.21M |
|
3188
MGE Energy Inc
MGEE
$3.02B
| $385K | ﹤0.01% |
5,182
-26,811
| -84% | -$2M |
|
|
EVBN
3189
DELISTED
Evans Bancorp Inc
EVBN
| $384K | ﹤0.01% |
10,352
-11,156
| -52% | -$407K |
|
3190
VanEck Agribusiness ETF
MOO
$976M
| $383K | ﹤0.01% |
+4,205
| New | +$385K |
|
3191
iShares Asia 50 ETF
AIA
$4.82B
| $382K | ﹤0.01% |
4,174
+3,449
| +476% | +$316K |
|
3192
Winmark
WINA
$1.27B
| $382K | ﹤0.01% |
1,989
-520
| -21% | -$101K |
|
|
TBRG
3193
DELISTED
TruBridge
TBRG
| $382K | ﹤0.01% |
11,505
-9,766
| -46% | -$310K |
|
3194
CALL
Exelixis
EXEL
$14.1B
| $381K | ﹤0.01% |
20,900
+20,000
| +2,222% | +$466K |
|
3195
Invesco DB Oil Fund
DBO
$359M
| $380K | ﹤0.01% |
+29,480
| New | +$346K |
|
3196
Inovio Pharmaceuticals
INO
$68.5M
| $380K | ﹤0.01% |
3,422
-9,580
| -74% | -$920K |
|
|
SHLX
3197
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $377K | ﹤0.01% |
25,527
-63,639
| -71% | -$954K |
|
3198
ASE Group
ASX
$85.1B
| $375K | ﹤0.01% |
+46,602
| New | +$375K |
|
3199
Greenlight Captial
GLRE
$543M
| $375K | ﹤0.01% |
41,149
-43,739
| -52% | -$401K |
|
3200
Helios Technologies
HLIO
$2.69B
| $375K | ﹤0.01% |
4,802
-23,515
| -83% | -$1.72M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.